Revisiting the roles of VHR/DUSP3 phosphatase in human diseases

• Main Authors: Lilian Cristina Russo, Jéssica Oliveira Farias, Pault Yeison Minaya Ferruzo, Lucas Falcão Monteiro, Fábio Luís Forti
• Format: Article
• Language: English
• Published: Faculdade de Medicina / USP 2018-09-01
• Series: Clinics
• Subjects: Protein tyrosine phosphatase (PTP); Vaccinia H1-related phosphatase (VHR); Dual-specificity phosphatase 3 (DUSP3); Mitogen-activated protein kinase (MAPK)
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322018000200315&lng=en&tlng=en

Protein tyrosine phosphatases have long been considered key regulators of biological processes and are therefore implicated in the origins of various human diseases. Heterozygosity, mutations, deletions, and the complete loss of some of these enzymes have been reported to cause neurodegenerative diseases, autoimmune syndromes, genetic disorders, metabolic diseases, cancers, and many other physiological imbalances. Vaccinia H1-related phosphatase, also known as dual-specificity phosphatase 3, is a protein tyrosine phosphatase enzyme that regulates the phosphorylation of the mitogen-activated protein kinase signaling pathway, a central mediator of a diversity of biological responses. It has been suggested that vaccinia H1-related phosphatase can act as a tumor suppressor or tumor-promoting phosphatase in different cancers. Furthermore, emerging evidence suggests that this enzyme has many other biological functions, such as roles in immune responses, thrombosis, hemostasis, angiogenesis, and genomic stability, and this broad spectrum of vaccinia H1-related phosphatase activity is likely the result of its diversity of substrates. Hence, fully identifying and characterizing these substrate-phosphatase interactions will facilitate the identification of pharmacological inhibitors of vaccinia H1-related phosphatase that can be evaluated in clinical trials. In this review, we describe the biological processes mediated by vaccinia H1-related phosphatase, especially those related to genomic stability. We also focus on validated substrates and signaling circuitry with clinical relevance in human diseases, particularly oncogenesis.